Clinical Trial Update: Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pharmacokinetics, efficacy, and safety of IMMUNATE SD (human plasma-derived Factor VIII concentrate) in Hemophilia A patients has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• IMMUNATE SD (Factor VIII concentrate)

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Hemophilia A | Phase 3 | Status: COMPLETED